Osteoporosis, bone & mineral

Effects of 25-Hydroxyvitamin D Levels on Renal Function: A Bidirectional Mendelian Randomization Study

J Clin Endocrinol MetabPublished Bidirectional two-sample Mendelian randomization study

Authors' conclusion

Genetically predicted CKD, increased BUN, and decreased eGFR are associated with increased 25(OH)D levels, but we found no causal effect of 25(OH)D on renal function in Europeans.

Study context

Population
Europeans: Single nucleotide polymorphisms (SNPs) for 25(OH)D from 443,734 individuals; GWAS of renal function totaling over 1 million25(OH)D GWAS
Participants
443,734 participants
Comparison
Genetically predicted 25D vs renal function, and the reverse
Outcome
Causal effect of 25(OH)D on eGFR, BUN, CKD risk and progression, and of renal function on 25(OH)D
Methodological detailsbidirectional (reverse Mendelian randomization (MR)), gene-restricted SNP analysis (DHCR7, CYP2R1, GC) to control pleiotropy
  • Bidirectional (reverse MR)
  • Gene-restricted SNP analysis (DHCR7, CYP2R1, GC) to control pleiotropy

Main finding

As reported in the abstract

Effect of 25(OH)D on renal function
  • No robust evidence of effects of 25(OH)D on estimated glomerular filtration rate (eGFR), blood urea nitrogen (BUN), and chronic kidney disease (CKD) or its progression

Further findings

Reverse MR: eGFR on standardized log-transformed 25(OH)D (per unit increase in log-transformed eGFR)

Decrease in standardized log-transformed 25(OH)D
0.56 (95% CI −0.73, −0.41; P = 2.89 × 10-12)
  • Inverse variance weighted MR

Reverse MR: BUN on 25(OH)D (per unit increase in log-transformed BUN)

β for increased 25(OH)D
0.25 (95% CI 0.15, 0.36; P = 4.12 × 10-6)

Reverse MR: genetically predicted CKD on standardized log-transformed 25(OH)D

Increase in standardized log-transformed 25(OH)D
0.05 (95% CI 0.04, 0.06; P = 1.06 × 10-13)
  • Other MR methods confirmed the findings

Original publication

Effects of 25-Hydroxyvitamin D Levels on Renal Function: A Bidirectional Mendelian Randomization Study. J Clin Endocrinol Metab. Published 13 December 2022. doi:10.1210/clinem/dgac724

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.